Abstract
Tacrolimus is an immunosuppressive medication in the class of calcineurin inhibitors that acts by inhibiting T-cell and interleukin-2 activity, and is commonly used after allogeneic organ transplant. We present a patient who used tacrolimus after cadaveric kidney transplant and experienced blurry vision. Ocular examination and patient's course subsequently revealed aqueous tear deficiency as a dose-dependent adverse effect of oral tacrolimus.
Original language | English (US) |
---|---|
Pages (from-to) | 137-139 |
Number of pages | 3 |
Journal | Cutaneous and Ocular Toxicology |
Volume | 29 |
Issue number | 2 |
DOIs | |
State | Published - Jun 2010 |
Externally published | Yes |
Keywords
- Aqueous tear deficiency
- Dry eyes
- FK506
- Prograf
- Tacrolimus
ASJC Scopus subject areas
- Toxicology